Crossref
Overcoming Acquired Resistance to Selective RET Inhibitors in RET -Mutant Medullary Thyroid Carcinoma
Clinical Thyroidology® · 01.08.2026 · 38 (8) · 286-289
DOI: 10.1177/23299711261475884 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Thyroidology®, online erschienen am 10.08.2026. Verfasst von Simone de Leo. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Leo, S. D. (2026). Overcoming Acquired Resistance to Selective RET Inhibitors in RET -Mutant Medullary Thyroid Carcinoma. Clinical Thyroidology®, 38(8), 286-289. https://doi.org/10.1177/23299711261475884
Vancouver
Leo SD. Overcoming Acquired Resistance to Selective RET Inhibitors in RET -Mutant Medullary Thyroid Carcinoma. Clinical Thyroidology®. 2026;38(8):286-289. doi:10.1177/23299711261475884
BibTeX
@article{Leo2026,
author = {Leo, Simone de},
title = {Overcoming Acquired Resistance to Selective RET Inhibitors in RET -Mutant Medullary Thyroid Carcinoma},
journal = {Clinical Thyroidology®},
year = {2026},
volume = {38},
number = {8},
pages = {286--289},
doi = {10.1177/23299711261475884}
}
EUVIMED